Pulmonary embolism (PE) remains a major contributor to global disease burden. Risk-
adapted treatment and follow-up contributes to a favorable outcome. Age-adjusted cutoff …

Pulmonary embolism (PE) is a serious and prevalent cause of vascular disease.
Nevertheless, optimal treatment for many phenotypes of PE remains uncertain. Treating PE …

We have updated recommendations on 12 controversial topics that were published in the
2013 National Consensus on the diagnosis, risk stratification and treatment of patients with …

Pulmonary embolism is a common and potentially fatal cardiovascular disorder that must be
promptly diagnosed and treated. The diagnosis, risk assessment, and management of …

Pulmonary embolism, despite being common, often remains elusive as a diagnosis, and
clinical suspicion needs to remain high when seeing a patient with cardiopulmonary …

The optimal treatment strategy for acute pulmonary embolism relies upon a multidisciplinary
team that rapidly assesses available data, performs additional testing if necessary, weighs …

Background Physicians treating acute pulmonary embolism (PE) are faced with difficult
management decisions while specific guidance from recent guidelines may be absent …

Pulmonary embolism (PE) is the leading cause of in-hospital death and the third most
frequent cause of cardiovascular death. The clinical presentation of PE is variable, and …

Compared with recent advances in treatment of serious cardiovascular diseases, such as
myocardial infarction and stroke, the treatment and outcome of acute pulmonary embolism …

Background: Despite advances in hospital management in recent years, it is not clear
whether mortality after acute pulmonary embolism (PE) has decreased over time. Objectives …